Searched for: in-biosketch:true
person:alin06
Landscape Of Post-Donation Follow-up of Living Kidney Donors in the United States, 2013-2023
Reed, Rhiannon D; Xue, Ruiqi; Thomas, Alvin G; Akhtar, Jasmine; Menon, Gayathri; Weiss, Samantha; Segev, Dorry L; Stewart, Darren E; Orandi, Babak J; Ali, Nicole M; Stern, Jeffrey M; Massie, Allan B; Levan, Macey L
Post-donation follow-up is critical for living kidney donor (LKD) care, facilitating early detection of unusual decrease in renal function and providing opportunities for early intervention. Herein, we update and characterize temporal trends in LKD follow-up (LDF) using Organ Procurement and Transplantation Network data. We identified 64,488 LKDs (2/2013-12/2023) and used logistic regression to assess donor characteristics associated with complete and timely (defined per current OPTN policy) LDF at 6-months, 1-year and 2-years post-donation. The proportion of complete and timely LDF submissions was generally consistent since 2013 for clinical and laboratory data at each time point. Overall, complete and timely 6-month, 1-year, and 2-year LDF were 84%, 81% and 75% for clinical data, and 80%, 75% and 68% for laboratory data. Across all time points, LKDs with pre-donation BMI≥30, Black race, and of younger age had higher odds of incomplete follow-up. We also observed substantial center-level variation, with the proportion of transplant centers meeting 6-month LDF thresholds ranging from 56-81% each year. In this retrospective registry analysis, LDF remained suboptimal and varied by center and donor characteristics, demonstrating the need for targeted approaches to improve LDF, particularly among those at increased risk of kidney disease or facing barriers to care.
PMID: 43003187
ISSN: 1600-6143
CID: 6075739
Offered Deceased Donor Kidneys With Little or No Chance of Being Transplanted
Chiang, Teresa Po-Yu; Husain, Syed Ali; Ali, Nicole M; Berger, Jonathan C; Orandi, Babak J; Massie, Allan B; Segev, Dorry L; Lonze, Bonnie E; Stewart, Darren E
BACKGROUND:With a broadening deceased donor pool and recent allocation policy changes, US transplant programs have reported challenges managing an influx of suboptimal kidney offers. We hypothesized that the number of offered kidneys with a minuscule chance of being transplanted has risen. If so, targeted innovations may be needed to reduce administrative burden and improve system efficiency. METHODS:Using Organ Procurement and Transplantation Network data on kidneys offered in 2016-2024, we developed a multivariable model to predict the probability that an offered kidney was transplanted (PrTx). We examined trends in the number and proportion of offered kidneys having PrTx ≤2%, ≤5%, and ≤10%. RESULTS:Donor factors most predictive of PrTx were age, donation after circulatory death, serum creatinine (terminal, peak, nadir), presence and duration of diabetes and hypertension, infectious disease test results, and body mass index. From 2016 to 2024, the annual number of kidneys offered with PrTx ≤2%, PrTx ≤5%, and PrTx ≤10% increased 13-fold (from 18 to 236), 12-fold (84 to 1055), and 10-fold (299 to 2856), respectively. Of the 236 offered kidneys with PrTx ≤2% in 2024, none was transplanted. The 2856 kidneys with PrTx ≤10% accounted for 7.9% (n = 1 208 883) of manually refused offers but just 1.1% (n = 239) of transplanted kidneys. Organ procurement organizations and centers varied substantially in offering and transplanting low-PrTx kidneys. CONCLUSIONS:The number of offered kidneys with extremely low predicted transplant probability has risen sharply, most notably in 2024. Innovations, such as improved offer filtering capabilities and standardized expedited allocation pathways, are needed to improve kidney placement efficiency.
PMID: 42957604
ISSN: 1534-6080
CID: 6074801
Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre-Existing Type 2 Diabetes
Lonze, Bonnie E; Husain, Syed Ali; Newsome, Jacey B; Thakur, Madhur; Weiss, Samantha A; Ali, Nicole M; Levan, Macey L; Thomas, Alvin G; Orandi, Babak J; Reed, Rhiannon D; Massie, Allan B; Segev, Dorry L; Stewart, Darren E
INTRODUCTION:In 2022, Organ Procurement and Transplantation Network policy was revised to permit living kidney donation by carefully selected individuals with type 2 diabetes mellitus (T2DM), which had previously been prohibited. Early evaluation is needed to understand adoption of this practice and short-term donor outcomes. METHODS:, and proteinuria. RESULTS:, (p = 0.12), and proteinuria was present in 12% of T2DM donors vs. 7% (p = 0.23). CONCLUSIONS:Living kidney donation by individuals with T2DM is uncommon but increasing. Though differences in early outcomes for T2DM vs. non-T2DM donors were not statistically significant, these null findings are based on small sample sizes and should not be interpreted as evidence of long-term safety. Careful donor selection and longer-term follow-up are needed to better define donor risk.
PMID: 42927437
ISSN: 1399-0012
CID: 6074713
Changes in Depressive Symptoms Pre- and Post-Kidney Transplantation
Huang, Nan-Su; Hong, Jingyao; Li, Yiting; Ghildayal, Nidhi; Ali, Nicole M; Crews, Deidra C; Cukor, Daniel; Mathur, Aarti; Orandi, Babak J; Norman, Silas P; Segev, Dorry L; McAdams-DeMarco, Mara A
BACKGROUND:Depressive symptoms are common in end-stage kidney disease (ESKD) patients, and may persist after stopping dialysis due to challenges post-KT despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT. METHODS:We leveraged a multi-center prospective cohort of 4,661 adult (aged ≥18) potential KT candidates and 1,215 recipients (2008-2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0-60, high depressive symptoms≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission. RESULTS:19% of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/year, 95% confidence interval [CI]:0.3, 0.6) but remained below the threshold for clinical depression. Post-KT CES-D score change differed by pre-KT high depressive symptoms score (difference=-1.2 points/year, 95%CI:-1.8, -0.6). Specifically, post-KT depressive symptoms were 0.7 points/year lower (95%CI:-1.2, -0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/year higher (95%CI:0.3, 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=-0.6 points/year, 95%CI:-1.0, -0.1, non-preemptive versus preemptive). CONCLUSIONS:Depressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
PMID: 42340755
ISSN: 2641-7650
CID: 6055862
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy
Bhoj, Vijay G; Kaminski, Mary; Zhao, Huiwu; Jackson, Kyle; Wang, Wei; Liu, Chengyang; Montgomery, Robert A; Ali, Nicole; Mangiola, Massimo; Spitzer, Thomas R; Safa, Kassem; Pattanayak, Vikram; Taj, Raeda; Chiu, Joy; Bui, Thanh-Mai; Sonnenberg, Elizabeth M; Markmann, James F; Milone, Michael C; June, Carl H; Siegel, Don L; Fraietta, Joseph A; Gonzalez, Vanessa; Locci, Michela; Palmer, Matthew; Monos, Dimitri; Hwang, Wei-Ting; Sledge, Tina; Bridges, Nancy D; Goldstein, Julia S; Odim, Jonah; Sweet, Stuart C; Besharatian, Behdad D; Hussain, Sabiha M; Brown, Nicholas K; Kamoun, Malek; Garfall, Alfred L; Naji, Ali
HLA sensitization poses a major challenge to kidney transplantation for patients with end-stage kidney disease, especially for highly sensitized candidates. Attempts at antibody elimination (desensitization) have had inconsistent efficacy and have often failed to produce sustained reductions in anti-HLA antibodies in patients with the highest level of sensitization (calculated panel-reactive antibody score, ≥99.9%). We now report the results for the safety run-in cohort of a multicenter phase 1 clinical study evaluating the safety and efficacy of combined CD19-targeted and B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T cells in eliminating the cellular sources of preformed anti-HLA antibodies (ClinicalTrials.gov number, NCT06056102). Kidney transplantation was performed in two highly sensitized candidates after desensitization with the use of dual CAR T-cell therapy.
PMCID:13240644
PMID: 42235014
ISSN: 1533-4406
CID: 6044112
Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant
Montgomery, Robert A; Stern, Jeffrey M; Fathi, Farshid; Suek, Nathan; Kim, Jacqueline I; Khalil, Karen; Vermette, Benjamin; Tatapudi, Vasishta S; Mattoo, Aprajita; Skolnik, Edward Y; Jaffe, Ian S; Aljabban, Imad; Eitan, Tal; Bisen, Shivani; Weldon, Elaina P; Goutaudier, Valentin; Morgand, Erwan; Mezine, Fariza; Giarraputo, Alessia; Boudhabhay, Idris; Bruneval, Patrick; Sannier, Aurelie; Breen, Kevin; Saad, Yasmeen S; Muntnich, Constanza Bay; Williams, Simon H; Zhang, Weimin; Kagermazova, Larisa; Schmauch, Eloi; Goparaju, Chandra; Dieter, Rebecca; Lawson, Nikki; Dandro, Amy; Fazio-Kroll, Ana Laura; Burdorf, Lars; Ayares, David; Lorber, Marc; Segev, Dorry; Ali, Nicole; Goldfarb, David S; Costa, Victoria; Hilbert, Timothy; Mehta, Sapna A; Herati, Ramin S; Pass, Harvey I; Wu, Ming; Boeke, Jef D; Keating, Brendan; Mangiola, Massimo; Sommer, Philip M; Loupy, Alexandre; Griesemer, Adam; Sykes, Megan
PMID: 42243534
ISSN: 1476-4687
CID: 6044562
The use of a centralized normothermic preservation and assessment center to rescue kidneys declined after standard allocation
Holzner, Matthew L; Jaynes, Chris L; Terlizzi, Kelly; Guerra, Giselle; Lonze, Bonnie E; Goggins, William; Barbas, Andrew; Kayler, Liise; Wellen, Jason; Lopez-Soler, Reynold; Berger, Jonathan C; Ali, Nicole M; van Leeuwen, Leonie; Philip, Jennifer; Shapiro, Ron; Massie, Allan B; Leuvenink, Henri; Garonzik-Wang, Jacqueline
Normothermic machine perfusion (NMP) may increase utilization of non-ideal donor kidneys through improved preservation and assessment. We assessed the use of a centralized perfusion service to rescue declined kidneys for transplant. Kidneys that exhausted standard OPTN allocation underwent 2 hours of NMP for additional assessment. The primary outcome was rescue for transplantation. Outcomes of NMP kidneys were compared to non-NMP kidneys transplanted during the study period at the same transplant centers. NMP was performed on 104 declined kidneys, and 94 (90%) were rescued for transplant. NMP donors were older, with a higher kidney donor profile index (KDPI) compared to non-NMP donors. Cold ischemia time was significantly longer in the NMP cohort (median 37.6 vs. 22.1 hours, p<0.001). The weighted percentage of delayed graft function (DGF) was 26.3% in the NMP group vs 60.2% in the non-NMP group (p=0.023). Overall graft survival was similar between the groups. With the use of a centralized NMP service, kidneys declined based on standard clinical parameters may be evaluated, rescued, and successfully transplanted. Kidneys undergoing NMP experienced significantly lower rates of DGF compared to non-NMP kidneys. Additional follow up is needed to determine the effects of NMP on long-term graft function.
PMID: 41796806
ISSN: 1600-6143
CID: 6015142
Publisher Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant
Montgomery, Robert A; Stern, Jeffrey M; Fathi, Farshid; Suek, Nathan; Kim, Jacqueline I; Khalil, Karen; Vermette, Benjamin; Tatapudi, Vasishta S; Mattoo, Aprajita; Skolnik, Edward Y; Jaffe, Ian S; Aljabban, Imad; Eitan, Tal; Bisen, Shivani; Weldon, Elaina P; Goutaudier, Valentin; Morgand, Erwan; Mezine, Fariza; Giarraputo, Alessia; Boudhabhay, Idris; Bruneval, Patrick; Sannier, Aurelie; Breen, Kevin; Saad, Yasmeen S; Muntnich, Constanza Bay; Williams, Simon H; Zhang, Weimin; Kagermazova, Larisa; Schmauch, Eloi; Goparaju, Chandra; Dieter, Rebecca; Lawson, Nikki; Dandro, Amy; Fazio-Kroll, Ana Laura; Burdorf, Lars; Ayares, David; Lorber, Marc; Segev, Dorry; Ali, Nicole; Goldfarb, David S; Costa, Victoria; Hilbert, Timothy; Mehta, Sapna A; Herati, Ramin S; Pass, Harvey I; Wu, Ming; Boeke, Jef D; Keating, Brendan; Mangiola, Massimo; Sommer, Philip M; Loupy, Alexandre; Griesemer, Adam; Sykes, Megan
PMID: 41680323
ISSN: 1476-4687
CID: 6002472
A Digital Health Framework to Assess Glycemia and Physical Activity in Kidney Transplant Candidates: A Pilot Study
Flaherty, Carina M; Sanchez, Christopher; Liu, Celina; Upadhyay, Dhairya; Segev, Dorry L; Ali, Nicole; Lee, Joseph; McAdams-DeMarco, Mara; Grams, Morgan E; Barua, Souptik
BACKGROUND/UNASSIGNED:Kidney transplant recipients are at risk for adverse health outcomes. Digital health tools such as wearable accelerometers and continuous glucose monitors (CGMs) can provide detailed, noninvasive tracking of health behaviors and measures, such as physical activity, sleep, and glucose levels, that may offer insights into future health concerns, such as posttransplant diabetes mellitus, cognitive health, and transplant rejection. However, there is limited evidence on the feasibility and acceptability of these devices in kidney transplant candidates older than 50 y. METHODS/UNASSIGNED:This observational cross-sectional pilot study aimed to examine the feasibility of 2 digital health tools: an accelerometer and a continuous glucose monitor. Participants were eligible for the study if they were living donor kidney transplant candidates, aged 50 y or older, had no known cognitive impairments, and could provide informed consent. Participants were asked to wear a CGM and an accelerometer for up to 14 d before their kidney transplant surgery. Device feasibility was quantified by (1) the total time the devices were worn, and (2) the validated System Usability Scale survey administered after the devices were returned. RESULTS/UNASSIGNED:20 participants enrolled in the study (mean age 64 ± 9 y, 25% women, 40% with type 2 diabetes). The median number of days of accelerometer and CGM wear were 7 (interquartile range, 6-10) d and 7 (interquartile range, 7-10) d, respectively. Ninety percent of participants reported a favorable opinion of both devices. Participants wore the CGM 100% of the time and the accelerometer 90% of the time, indicating high adherence. CONCLUSIONS/UNASSIGNED:The use of digital devices was acceptable among kidney transplant candidates aged older than 50 y, paving the way for larger studies to identify early digital biomarkers of health outcomes in this high-risk population.
PMCID:12818855
PMID: 41567755
ISSN: 2373-8731
CID: 5988542
Physiology and immunology of pig-to-human decedent kidney xenotransplant
Montgomery, Robert A; Stern, Jeffrey M; Fathi, Farshid; Suek, Nathan; Kim, Jacqueline I; Khalil, Karen; Vermette, Benjamin; Tatapudi, Vasishta S; Mattoo, Aprajita; Skolnik, Edward Y; Jaffe, Ian S; Aljabban, Imad; Eitan, Tal; Bisen, Shivani; Weldon, Elaina P; Goutaudier, Valentin; Morgand, Erwan; Mezine, Fariza; Giarraputo, Alessia; Boudhabhay, Idris; Bruneval, Patrick; Sannier, Aurelie; Breen, Kevin; Saad, Yasmeen S; Muntnich, Constanza Bay; Williams, Simon H; Zhang, Weimin; Kagermazova, Larisa; Schmauch, Eloi; Goparaju, Chandra; Dieter, Rebecca; Lawson, Nikki; Dandro, Amy; Fazio-Kroll, Ana Laura; Burdorf, Lars; Ayares, David; Lorber, Marc; Segev, Dorry; Ali, Nicole; Goldfarb, David S; Costa, Victoria; Hilbert, Timothy; Mehta, Sapna A; Herati, Ramin S; Pass, Harvey I; Wu, Ming; Boeke, Jef D; Keating, Brendan; Mangiola, Massimo; Sommer, Philip M; Loupy, Alexandre; Griesemer, Adam; Sykes, Megan
Xenotransplantation of genetically-modified pig kidneys offers a solution to the scarcity of organs for end-stage renal disease patients.1 We performed a 61-day alpha-Gal knock-out pig kidney and thymic autograft transplant into a nephrectomized brain-dead human using clinically approved immunosuppression, without CD40 blockade or additional genetic modification. Hemodynamic and electrolyte stability and dialysis independence were achieved. Post-operative day (POD) 10 biopsies revealed glomerular IgM and IgA deposition, activation of early complement components and mesangiolysis with stable renal function without proteinuria, a phenotype not seen in allotransplantation. On POD 33, an abrupt increase in serum creatinine was associated with antibody-mediated rejection and increased donor-specific IgG. Plasma exchange, C3/C3b inhibition and rabbit anti-thymocyte globulin (rATG), completely reversed xenograft rejection. Pre-existing donor-reactive T cell clones expanded progressively in the circulation post-transplant, acquired an effector transcriptional profile and were detected in the POD 33 rejecting xenograft prior to rATG treatment. This study provides the first long-term physiologic, immunologic, and infectious disease monitoring of a pig-to-human kidney xenotransplant and indicates that pre-existing xenoreactive T cells and induced antibodies to unknown epitope(s) present a major challenge, despite significant immunosuppression. It also demonstrates that a minimally gene-edited pig kidney can support long-term life-sustaining physiologic functions in a human.
PMID: 41233546
ISSN: 1476-4687
CID: 5967072